HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation

Sung, 2021, Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J Clin, 71, 209, 10.3322/caac.21660 Yang, 2019, A global view of hepatocellular carcinoma: trends, risk, prevention and management, Nat Rev Gastroenterol Hepatol, 16, 589, 10.1038/s41575-019-0186-y Akce, 2022, Frontline therapy for advanced hepatocellular carcinoma: an update, Therap Adv Gastroenterol, 15, 10.1177/17562848221086126 Hanahan, 2000, The hallmarks of cancer, Cell, 100, 57, 10.1016/S0092-8674(00)81683-9 Hanahan, 2011, Hallmarks of cancer: the next generation, Cell, 144, 646, 10.1016/j.cell.2011.02.013 Kuzu, 2016, The role of cholesterol in cancer, Cancer Res, 76, 2063, 10.1158/0008-5472.CAN-15-2613 Kroemer, 2008, Tumor cell metabolism: cancer’s Achilles’ heel, Cancer Cell, 13, 472, 10.1016/j.ccr.2008.05.005 Riscal, 2019, Even cancer cells watch their cholesterol, Mol Cell, 76, 220, 10.1016/j.molcel.2019.09.008 Lee, 2022, Platycodin D inhibits autophagy and increases glioblastoma cell death via LDLR upregulation, Mol Oncol, 16, 250, 10.1002/1878-0261.12966 Marques, 2019, Multimerization and retention of the scavenger receptor SR-B1 in the plasma membrane, Dev Cell, 50, 283, 10.1016/j.devcel.2019.05.026 Teratani, 2019, Lipoprotein lipase up-regulation in hepatic stellate cells exacerbates liver fibrosis in nonalcoholic steatohepatitis in mice, Hepatol Commun, 3, 1098, 10.1002/hep4.1383 Cheng, 2017, 8 Woo, 2019, Phenotype of vigilin expressing breast cancer cells binding to the 69 nt 3'UTR element in CSF-1R mRNA, Transl Oncol, 12, 106, 10.1016/j.tranon.2018.09.012 Yang, 2014, Vigilin is overexpressed in hepatocellular carcinoma and is required for HCC cell proliferation and tumor growth, Oncol Rep, 31, 2328, 10.3892/or.2014.3111 Uhlén, 2015, Proteomics. Tissue-based map of the human proteome, Science, 347, 10.1126/science.1260419 Gollob, 2006, Role of Raf kinase in cancer: therapeutic potential of targeting the Raf/MEK/ERK signal transduction pathway, Semin Oncol, 33, 392, 10.1053/j.seminoncol.2006.04.002 Karandikar, 2000, MEKK1 binds raf-1 and the ERK2 cascade components, J Biol Chem, 275, 40120, 10.1074/jbc.M005926200 Gauthier, 2013, Role of sorafenib in the treatment of advanced hepatocellular carcinoma: an update, Hepatol Res, 43, 147, 10.1111/j.1872-034X.2012.01113.x Yuan, 2019, Interferon regulatory factor-1 reverses chemoresistance by downregulating the expression of P-glycoprotein in gastric cancer, Cancer Lett, 457, 28, 10.1016/j.canlet.2019.05.006 Kanarek, 2012, Regulation of NF-κB by ubiquitination and degradation of the IκBs, Immunol Rev, 246, 77, 10.1111/j.1600-065X.2012.01098.x Zhou, 2008, On the mechanism of induction of heterochromatin by the RNA-binding protein vigilin, RNA, 14, 1773, 10.1261/rna.1036308 Yang, 2018, PIM2-mediated phosphorylation of hexokinase 2 is critical for tumor growth and paclitaxel resistance in breast cancer, Oncogene, 37, 5997, 10.1038/s41388-018-0386-x Shu, 2008, GRP78 and Raf-1 cooperatively confer resistance to endoplasmic reticulum stress-induced apoptosis, J Cell Physiol, 215, 627, 10.1002/jcp.21340 Wang, 2005, Hepatocyte growth factor enhances protein phosphatase Cdc25A inhibitor compound 5-induced hepatoma cell growth inhibition via Akt-mediated MAPK pathway, J Cell Physiol, 203, 510, 10.1002/jcp.20243 Wilhelm, 2006, Discovery and development of sorafenib: a multikinase inhibitor for treating cancer, Nat Rev Drug Discov, 5, 835, 10.1038/nrd2130 Gordan, 2020, Systemic therapy for advanced hepatocellular carcinoma: ASCO Guideline, J Clin Oncol, 38, 4317, 10.1200/JCO.20.02672 Tian, 2020, RAF1 expression is correlated with HAF, a parameter of liver computed tomographic perfusion, and may predict the early therapeutic response to sorafenib in advanced hepatocellular carcinoma patients, Open Med (Wars), 15, 167, 10.1515/med-2020-0024 Dougherty, 2005, Regulation of Raf-1 by direct feedback phosphorylation, Mol Cell, 17, 215, 10.1016/j.molcel.2004.11.055 O’Neill, 2004, Role of the kinase MST2 in suppression of apoptosis by the proto-oncogene product Raf-1, Science, 306, 2267, 10.1126/science.1103233 Andreu-Pérez, 2011, Protein arginine methyltransferase 5 regulates ERK1/2 signal transduction amplitude and cell fate through CRAF, Sci Signal, 4, ra58, 10.1126/scisignal.2001936 Hayes, 2012, Direct and indirect control of mitogen-activated protein kinase pathway-associated components, BRAP/IMP E3 ubiquitin ligase and CRAF/RAF1 kinase, by the deubiquitylating enzyme USP15, J Biol Chem, 287, 43007, 10.1074/jbc.M112.386938 Jang, 2015, Spatial control of Shoc2-scaffold-mediated ERK1/2 signaling requires remodeling activity of the ATPase PSMC5, J Cell Sci, 128, 4428 Su, 2019, Long-term culture and characterization of patient-derived primary hepatocytes using conditional reprogramming, Exp Biol Med (Maywood), 244, 857, 10.1177/1535370219855398 Yuan, 2019, MIR17HG-miR-18a/19a axis, regulated by interferon regulatory factor-1, promotes gastric cancer metastasis via Wnt/β-catenin signalling, Cell Death Dis, 10, 454, 10.1038/s41419-019-1685-z Tan, 2020, Interferon regulatory factor-1 suppresses DNA damage response and reverses chemotherapy resistance by downregulating the expression of RAD51 in gastric cancer, Am J Cancer Res, 10, 1255 Yuan, 2019, GLIS2 redundancy causes chemoresistance and poor prognosis of gastric cancer based on co-expression network analysis, Oncol Rep, 41, 191 Yuan, 2019, Bioinformatics analysis identifies potential chemoresistance-associated genes across multiple types of cancer, Oncol Lett, 18, 2576